BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25111897)

  • 21. Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation.
    de Graauw M; Cao L; Winkel L; van Miltenburg MH; le Dévédec SE; Klop M; Yan K; Pont C; Rogkoti VM; Tijsma A; Chaudhuri A; Lalai R; Price L; Verbeek F; van de Water B
    Oncogene; 2014 May; 33(20):2610-9. PubMed ID: 23792445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor structural alterations in gastric cancer.
    Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
    BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VPS52 induces apoptosis via cathepsin D in gastric cancer.
    Zhang J; Lin Y; Hu X; Wu Z; Guo W
    J Mol Med (Berl); 2017 Oct; 95(10):1107-1116. PubMed ID: 28791438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2,4‑Di‑tert‑butylphenol, a potential HDAC6 inhibitor, induces senescence and mitotic catastrophe in human gastric adenocarcinoma AGS cells.
    Song YW; Lim Y; Cho SK
    Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):675-683. PubMed ID: 29427610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis.
    Wang SA; Wang YC; Chuang YP; Huang YH; Su WC; Chang WC; Hung JJ
    Oncogene; 2017 May; 36(21):2930-2945. PubMed ID: 27991932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Hdac6 enhances resistance to virus infection in embryonic stem cells and in mice.
    Wang D; Meng Q; Huo L; Yang M; Wang L; Chen X; Wang J; Li Z; Ye X; Liu N; Li Q; Dai Z; Ouyang H; Li N; Zhou J; Chen L; Liu L
    Protein Cell; 2015 Feb; 6(2):152-6. PubMed ID: 25482409
    [No Abstract]   [Full Text] [Related]  

  • 28. Signaling pathways of oxidative stress response: the potential therapeutic targets in gastric cancer.
    Liu Y; Shi Y; Han R; Liu C; Qin X; Li P; Gu R
    Front Immunol; 2023; 14():1139589. PubMed ID: 37143652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer: Gene fusion identified in gastric cancer.
    Greenhill C
    Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(6):301. PubMed ID: 21643030
    [No Abstract]   [Full Text] [Related]  

  • 30. MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer.
    Bae HJ; Jung KH; Eun JW; Shen Q; Kim HS; Park SJ; Shin WC; Yang HD; Park WS; Lee JY; Nam SW
    J Hepatol; 2015 Aug; 63(2):408-19. PubMed ID: 25817558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib in non-Hodgkin lymphoma cells.
    Dasmahapatra G; Patel H; Friedberg J; Quayle SN; Jones SS; Grant S
    Mol Cancer Ther; 2014 Dec; 13(12):2886-97. PubMed ID: 25239935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy.
    Wen Y; Ye S; Li Z; Zhang X; Liu C; Wu Y; Zheng R; Xu C; Tian J; Shu L; Yan Q; Ai F; Ma J
    Cancer Immunol Immunother; 2024 Jan; 73(1):7. PubMed ID: 38231305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS.
    Yin G; Huang J; Petela J; Jiang H; Zhang Y; Gong S; Wu J; Liu B; Shi J; Gao Y
    Signal Transduct Target Ther; 2023 May; 8(1):212. PubMed ID: 37221195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
    Badie A; Gaiddon C; Mellitzer G
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance.
    Jo H; Shim K; Jeoung D
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of DNA Methylation Profile Associated with TCM Syndrome in Endometriosis.
    Wang X; Zhang Z; Zeng W; Zhong Y; Xie D; Zhu W; Chen F; Du J; Zhang T
    Evid Based Complement Alternat Med; 2022; 2022():4866360. PubMed ID: 35449808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC6/FOXP3/HNF4α axis promotes bile acids induced gastric intestinal metaplasia.
    Zhang L; Wang N; Chen M; Wu S; Zeng J; Zhou F; Wu Q; Liu J; Shi Y
    Am J Cancer Res; 2022; 12(3):1409-1422. PubMed ID: 35411233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses.
    Tu J; Fang Y; Han D; Tan X; Xu Z; Jiang H; Wang X; Hong W; Wei W
    Oncogene; 2022 Apr; 41(17):2444-2457. PubMed ID: 35279703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer.
    Zhou B; Liu D; Tan Y
    Front Cell Dev Biol; 2021; 9():719390. PubMed ID: 34938729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine.
    Zhang XM; Gavande N; Parajuli P; Bepler G
    J Cancer Biol; 2021; 2(1):. PubMed ID: 34746935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.